UROCIT-K

This brand name is authorized in United States. It is also authorized in Austria, Canada, Ecuador, Estonia, Hong Kong SAR China, Israel, Singapore, South Africa, Turkey.

Active ingredients

The drug UROCIT-K contains one active pharmaceutical ingredient (API):

1	Potassium citrate UNII EE90ONI6FF - POTASSIUM CITRATE
	Citrate and citric acid solutions are systematic and urinary alkalinizers thereby providing symptomatic relief of dysuria.
	Read more about Potassium citrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
UROCIT-K Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A12BA02	Potassium citrate	A Alimentary tract and metabolism → A12 Mineral supplements → A12B Potassium → A12BA Potassium
Discover more medicines within A12BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	01914022, 02353997
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.514-02-07
EE	Ravimiamet	1800469
HK	Department of Health Drug Office	47513
IL	מִשְׂרַד הַבְּרִיאוּת	7919
SG	Health Sciences Authority	08734P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699771010015, 8699771030020
US	FDA, National Drug Code	0178-0600, 0178-0610, 0178-0615
ZA	Health Products Regulatory Authority	49/18.3/0005